NDRA
ENDRA Life Sciences Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$4.94
+1.65%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 24.70x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.17x
- Price / sales
- —
- Price / cash flow
- -1.54x
Enterprise value
- Enterprise value
- $6.1M
- EV / sales
- —
- EV / EBITDA
- -0.82x
- EV / EBIT
- -0.92x
- Market cap
- $7.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026